Trending

FDA announces recall of 2 cardiovascular medications due to labeling mix-up
New recommendations highlight the importance of CCTA when treating acute chest pain in the ED
Underdiagnosed and undertreated: How cardiologists and primary care physicians are working together to identify patients with severe aortic stenosis
Q&A: What the impressive durability of self-expanding TAVR valves means for patient care, shared decision-making
Earlier interventions may boost survival when TAVR patients experience a stroke
Leadership
Industry insights: 4 healthcare executives discuss the biggest challenges in cardiology today

We spoke to executives from some of healthcare's most prominent vendors to find out what challenges are on their radar in 2022 and beyond. 

EP ablation mapping technology has greatly improved in the past decade.
VIDEO: Advances in atrial fibrillation treatment have improved outcomes

Interview with Dhanunjaya Lakkireddy, MD, executive medical director for the Kansas City Heart Rhythm Institute at HCA Midwest Health, on recent advances in electrophysiology (EP) ablation and mapping systems to improve outcomes in atrial fibrillation therapy.

ecg_electrocardiogram.jpg
AI model uses ECG data to identify new cases of AFib

“Our ultimate goal is to prevent strokes," one Mayo Clinic electrophysiologist said. "I believe the current study has brought us one step closer.”

Product Recall
FDA announces Class I recall of circulatory support system after 66 complaints, 2 patient injuries

The recall is due to a malfunction risk that could, if not handled properly, cause the pump to stop working for a long period of time. This could lead to a serious injury or death, according to the recall. 

Preventing AKI after TAVR may help lessen the impact of chronic kidney disease

If researchers can find ways to prevent AKI after TAVR, it could help decrease the risk of poor outcomes in more ways than one. 

Cardiovascular information systems (CVIS) combine imaging and reporting into one system that allows access across the cardiovascular service line. Here are 7 trends in CVIS according to KLAS.
VIDEO: 7 trends in cardiovascular information systems seen by KLAS

Monique Rasband, vice president of imaging, cardiology and oncology, KLAS Research, explains a few of the key technology trends in cardiovascular information systems (CVIS).

FDA recall. The medications involved are atenolol, which treats hypertension, and the antiplatelet agent clopidogrel, which reduces the risk of an acute myocardial infarction (AMI) or stroke among patients with a history of AMI, severe chest pain or circulation problems.
FDA announces recall of 2 cardiovascular medications due to labeling mix-up

Patients face a risk of adverse events if they mistakenly take the wrong medication, according to a new warning from the FDA. 

Innovation at work

Cardiovascular Business
Q&A: What the impressive durability of self-expanding TAVR valves means for patient care, shared decision-making

Updates about transcatheter aortic valve replacement (TAVR) are always big news, but the new five-year data from the CoreValve™ US Pivotal and SURTAVI trials came as a welcome surprise to many cardiologists. 

Sponsored by Medtronic

Around the web

Health Exec
More than 100 medical societies push Congress to end destructive cycle of annual Medicare cuts

More than 120 medical societies have joined the AMA in a letter urging congressional leaders to enact long-term solutions to the systemic problems in the Medicare physician payment system and to address cuts that are going into effect in 2023.

Health Imaging
PHOTO GALLERY: COVID-19 clinical imaging presentations

This image gallery shows what the various clinical presentations associated with the COVID-19 virus that have been documented during the coronavirus pandemic.

COVID-19

Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Myocarditis risk higher after COVID-19 infection than after vaccination, new study of 43 million patients confirms
American Heart Association 2022 late-breaking studies announced
1 in 20 hospitalized COVID-19 patients develop new-onset AFib
Myocarditis risk higher after COVID-19 infection than after vaccination, new study of 43 million patients confirms
PET imaging uncovers a surprising new way COVID-19 affects the heart
MORE »

Heart Failure

USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older.
HFpEF patients with MR may face a higher mortality risk—but not if they have AFib
American Heart Association 2022 late-breaking studies announced
HFpEF patients with MR may face a higher mortality risk—but not if they have AFib
Cardiologists identify a potential new side effect of monkeypox: acute myocarditis
FDA announces a new recall of more than 23,000 batteries for Medtronic’s HVAD system
MORE »

Heart Rhythm

ecg_electrocardiogram.jpg
AI model uses ECG data to identify new cases of AFib
AI model uses ECG data to identify new cases of AFib
Drinking coffee linked to a much lower risk of heart disease, death
VIDEO: Gaps in the access to atrial fibrillation care
FDA grants new pediatric indication for Medtronic Linq II implantable cardiac monitor 
MORE »

Vascular & Endovascular

When kidney cancer invades a patient’s inferior vena cava (IVC), robotic-assisted radical nephrectomy with IVC thrombectomy is a safe and effective alternative to open surgery, according to a new meta-analysis published in the Journal of Urology.[1]
Robotic IVC thrombectomy: A safe, effective alternative to open surgery
Earlier interventions may boost survival when TAVR patients experience a stroke
Pulmonary artery denervation shows promise to treat pulmonary arterial hypertension
Ultrasound guidance for femoral access did not reduce bleeding or vascular complications in TCT late-breaker
Blood clots much more common among obese women taking combination birth control pills
MORE »
Design by Adaptivethemes.com